Stock Alert: Marico, Allied Blenders & Distillers, Star Health & Allied Insurance, Moitsons Jewellers (30-10-2024)
DFC First Bank, IndiaMart Intermesh, L&T Finance, Manappuram Finance, PNB, RBL Bank.
Automakers On Luxe Top Gear To Woo Buyers (30-10-2024)
Armed with swanky showrooms, decked with plush fixtures, and offering indulgences such as high-end perfumes and customisable accessories, BMW, Mercedes, Audi are rolling out the red carpet for the well-heeled.
Nifty futures indicate flat opening; traders eye sector-specific moves amid volatility (30-10-2024)
With Nifty futures trading near Tuesday’s close, and key open interest levels indicating resistance around 24,500–25,000 and support at 24,000–24,400, the market may remain range-bound
Dividend stocks: NTPC, Tech Mahindra, & 11 others to remain in focus today (30-10-2024)
Here is the complete list of companies whose shares will turn ex-dividend date tomorrow along with other key details
Bullish on pharma, especially CDMO; slightly negative on auto: Daljeet Kohli (30-10-2024)
Daljeet Kohli of Roha Asset Managers LLP is bullish on the pharma sector, anticipating strong performance over the next one-two years. He mentions the Biosecure Act of the US and the potential growth for companies involved in CDMO, CMO, and CRMO. Kohli expresses caution towards the auto sector, noting that its recent rally may be slowing down.
Marico shares in focus after company reports 20% YoY growth in PAT (30-10-2024)
Marico reported a 20% increase in consolidated net profit to Rs 433 crore for the September quarter, up from Rs 360 crore a year ago. Consolidated revenue rose by 7.6% to Rs 2,664 crore, with domestic revenue up 8.02% and international revenue rising 6.36%.
Dabur India shares in focus ahead of Q2 results today (30-10-2024)
FMCG major Dabur India’s second quarter results are likely to show a muted performance due to declining volumes and distributor inventory correction. Revenue is expected to drop by 5% and net profit by 8% year-on-year. The international business might see double-digit growth. Consolidated EBITDA is projected to decline by 17%, with tightened margins amid increased marketing expenses.